US Bancorp’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-100
| Closed | -$1.97K | – | 4088 |
|
|
2024
Q2 | $1.97K | Buy |
100
+33
| +49% | +$661 | ﹤0.01% | 3721 |
|
|
2024
Q1 | $1.72K | Sell |
67
-96
| -59% | -$2.46K | ﹤0.01% | 3749 |
|
|
2023
Q4 | $4.5K | Buy |
163
+90
| +123% | +$5.49K | ﹤0.01% | 3560 |
|
|
2023
Q3 | $4.43K | Sell |
73
-303
| -81% | -$21.3K | ﹤0.01% | 3473 |
|
|
2023
Q2 | $24.7K | Buy |
376
+338
| +889% | +$24.7K | ﹤0.01% | 2874 |
|
|
2023
Q1 | $2.42K | Sell |
38
-124
| -77% | -$14.2K | ﹤0.01% | 3707 |
|
|
2022
Q4 | $22.5K | Sell |
162
-234
| -59% | -$33K | ﹤0.01% | 2942 |
|
|
2022
Q3 | $50K | Buy |
396
+278
| +236% | +$31.5K | ﹤0.01% | 2529 |
|
|
2022
Q2 | $10K | Sell |
118
-306
| -72% | -$23.7K | ﹤0.01% | 3356 |
|
|
2022
Q1 | $41K | Buy |
424
+192
| +83% | +$25.3K | ﹤0.01% | 2719 |
|
|
2021
Q4 | $47K | Buy |
232
+162
| +231% | +$38.2K | ﹤0.01% | 2689 |
|
|
2021
Q3 | $17K | Sell |
70
-479
| -87% | -$137K | ﹤0.01% | 3199 |
|
|
2021
Q2 | $227K | Buy |
549
+62
| +13% | +$24.6K | ﹤0.01% | 1922 |
|
|
2021
Q1 | $190K | Buy |
487
+388
| +392% | +$191K | ﹤0.01% | 1944 |
|
|
2020
Q4 | $55K | Sell |
99
-49
| -33% | -$31.1K | ﹤0.01% | 2476 |
|
|
2020
Q3 | $103K | Sell |
148
-203
| -58% | -$158K | ﹤0.01% | 2063 |
|
|
2020
Q2 | $277K | Sell |
351
-64
| -15% | -$48.3K | ﹤0.01% | 1599 |
|
|
2020
Q1 | $247K | Buy |
415
+194
| +88% | +$189K | ﹤0.01% | 1551 |
|
|
2019
Q4 | $252K | Sell |
221
-94
| -30% | -$102K | ﹤0.01% | 1719 |
|
|
2019
Q3 | $375K | Sell |
315
-3
| -0.9% | -$4.58K | ﹤0.01% | 1498 |
|
|
2019
Q2 | $524K | Hold |
318
| – | – | ﹤0.01% | 1379 |
|
|
2019
Q1 | $649K | Buy |
318
+87
| +38% | +$153K | ﹤0.01% | 1264 |
|
|
2018
Q4 | $297K | Sell |
231
-103
| -31% | -$158K | ﹤0.01% | 1576 |
|
|
2018
Q3 | $632K | Buy |
334
+22
| +7% | +$45.4K | ﹤0.01% | 1333 |
|
|
2018
Q2 | $634K | Hold |
312
| – | – | ﹤0.01% | 1334 |
|
|
2018
Q1 | $689K | Buy |
312
+310
| +15,500% | +$788K | ﹤0.01% | 1279 |
|
|
2017
Q4 | $6K | Sell |
2
-13
| -87% | -$26.4K | ﹤0.01% | 3268 |
|
|
2017
Q3 | $27K | Buy |
+15
| New | +$21K | ﹤0.01% | 2783 |
|
|
2016
Q4 | – | Sell |
-90
| Closed | -$79K | – | 3541 |
|
|
2016
Q3 | $79K | Buy |
+90
| New | +$65.2K | ﹤0.01% | 2213 |
|
|
2016
Q2 | – | Sell |
-3
| Closed | -$2K | – | 3546 |
|
|
2016
Q1 | $2K | Buy |
+3
| New | +$1.84K | ﹤0.01% | 3351 |
|
|
2015
Q4 | – | Sell |
-333
| Closed | -$369K | – | 3603 |
|
|
2015
Q3 | $369K | Hold |
333
| – | – | ﹤0.01% | 1426 |
|
|
2015
Q2 | $726K | Sell |
333
-58
| -15% | -$118K | ﹤0.01% | 1176 |
|
|
2015
Q1 | $612K | Buy |
391
+329
| +531% | +$434K | ﹤0.01% | 1264 |
|
|
2014
Q4 | $73K | Buy |
+62
| New | +$41.4K | ﹤0.01% | 2329 |
|
Other funds holding BLUE
APM
LPC
US Bancorp's BLUE Position: Q3 2024 in Review
US Bancorp sold out of bluebird bio (BLUE) in Q3 2024, closing a stake of 100 shares — an estimated $1.97K sold.
US Bancorp first reported a position in BLUE in Q4 2014 and held it in 34 quarters. The position peaked at $726K in Q2 2015. 140 funds tracked by Wall St. Rank hold BLUE as of Q3 2024.
- US Bancorp reported no remaining bluebird bio position as of Q3 2024 after selling out during the quarter.
- US Bancorp sold 100 bluebird bio shares in Q3 2024, an estimated $1.97K.
- US Bancorp first reported a position in bluebird bio in Q4 2014 and held it in 34 quarters.
- US Bancorp's bluebird bio position peaked at $726K in Q2 2015.
- 140 funds tracked by Wall St. Rank held bluebird bio as of Q3 2024.
Based on US Bancorp's 13F filing for Q3 2024, filed 28 Oct 2024.